Shasun Of India Sees Double Sales Selling Ingredients Of Expiring Drugs
This article was originally published in PharmAsia News
Executive Summary
India's Shasun Pharmaceuticals expects to double its sales in the next three years based on supplying to generic drug makers the main ingredients for patent-losing drugs, such as of Pfizer's Advil (chlorpheniramine).